Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
06/2004
06/22/2004US6753008 Dietary supplements beneficial for the liver
06/22/2004US6752994 Microorganismal cell model for use as tool in treatment of tuberculosis, skin disorders and infections
06/22/2004US6752992 Bacillus endotoxin for controlling moths; cry proteins
06/20/2004CA2453872A1 Heat-labile desoxyribonuclease i variants
06/19/2004CA2423904A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene
06/17/2004WO2004050985A1 Removal of pitch from wood chips
06/17/2004WO2004050892A1 Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof
06/17/2004WO2004050875A1 Novel aromatic ring dioxygenase genes and use thereof
06/17/2004WO2004050869A1 PROTEIN BINDING TO Akt2
06/17/2004WO2004050863A1 Microorganism for producing riboflavin and method for producing riboflavin using the same
06/17/2004WO2004050862A1 Microorganism for producing riboflavin and method for producing riboflavin using the same
06/17/2004WO2004050861A1 The microbial preparation & method for preventing and curing the bacterial wilt the plant and its use
06/17/2004WO2004050684A2 Methods for improving secondary metabolite production in fungi
06/17/2004WO2004050675A1 Concurrent microorganism identification and susceptibilities from broth
06/17/2004WO2004050017A2 Rationally designed antibodies
06/17/2004WO2004034989A9 Probiotic bacteria
06/17/2004WO2004028460A3 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
06/17/2004WO2004011609A3 Methods for producing biological substances in pigment-deficient mutants of bacillus cells
06/17/2004WO2003102213A3 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
06/17/2004WO2003102138A3 Elongase genes and uses thereof
06/17/2004WO2003087145A3 Purified polypeptides involved in quorum sensing
06/17/2004WO2003044165A3 Genetically modified bacterial strains and novel vectors for use in expressing and assaying natural products
06/17/2004WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
06/17/2004US20040117873 Plant into which symbiotic fungus is artificially introduced, and method of introducing symbiotic fungus into plant
06/17/2004US20040117872 Expression vector comprising nucleotide sequences coding arogenate dehydrogenase for transformation and propagation of glyphosate resistant plants
06/17/2004US20040116672 Human sel-10 polypeptides and polynucleotides that encode them
06/17/2004US20040116665 Vaccine composition
06/17/2004US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine
06/17/2004US20040116355 Caspase inhibitors and the use thereof
06/17/2004US20040115816 Modifying corynebacterial or brevibacterial genomes with plasmid vector in order to express levan sucrase; gene transfer reporter gene expression; transcriptional patterning
06/17/2004US20040115811 Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic molecule
06/17/2004US20040115792 Yeast strain for testing the geno- and cytotoxicity of complex environmental contaminations
06/17/2004US20040115791 Method and system of disposing food wastes
06/17/2004US20040115790 Method for production of secreted proteins in fungi
06/17/2004US20040115781 Extraction from solution; purification; salt formin g using aqueous solution of sodium hydroxide; scavenging using water insoluble ion exchange resin
06/17/2004US20040115780 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an atteuated aspa gene
06/17/2004US20040115773 Serpin in bifidobacteria
06/17/2004US20040115772 Methods of inhibiting Helicobacter pylori
06/17/2004US20040115769 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
06/17/2004US20040115763 having a beta 1,3-N-acetylglucosaminyltransferase activity; for diagnosis and treatment for inflammatory diseases, cancer or tumor metastasis
06/17/2004US20040115762 Comprises nucleotide sequences coding enzymatic polypeptide associated biosynthesis of nystatin and treatment of bacterial, fungal and parasitic infections; immunosuppressant; antitumor agents
06/17/2004US20040115761 Polypeptides and nucleic acids encoding same
06/17/2004US20040115695 Methods for generating enhanced antibody producing cell lines with improved growth characteristics
06/17/2004US20040115673 Comprises nucleotide sequences coding enzymatic polypeptide for expression and propagation in heterologous microorganisms; bioreactors and trangenic protein expression
06/17/2004US20040115666 Method for identifying compounds modulating reverse cholesterol transport
06/17/2004US20040115657 Methanotrophic carbon metabolism pathway genes and enzymes
06/17/2004US20040115614 Measuring physiological response in cell via electric field stimulation
06/17/2004US20040115308 Consumable product containing probiotics
06/17/2004US20040115306 Prolyl-specific endoprotease is added to the beverage
06/17/2004US20040115221 Intracellular delivery vehicles
06/17/2004US20040115220 Vaccine
06/17/2004US20040115215 Recombinant botulinum toxins with a soluble C-terminal portion, an N-terminal portion and a light chain
06/17/2004US20040115212 Attenuated microorganism strains and their uses
06/17/2004US20040115199 Method for down-regulating osteoprotegerin ligand activity
06/17/2004US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing
06/17/2004US20040115179 treating and preventing gastrointestinal diseases as well as lowering serum cholesterol
06/17/2004US20040115178 hydrophobic surface
06/17/2004US20040115171 Novel antagonistic yeast useful in controlling spoilage of agricultural produce methods of use thereof and compositions containg same
06/17/2004DE10254074A1 Verfahren zur mikrobiellen Herstellung von Stoffwechselprodukten A process for the microbial production of metabolic products
06/17/2004DE10248166A1 Anti-Kazlauskas-Lipasen Anti-Kazlauskas lipases
06/17/2004CA2549213A1 Concurrent microorganism identification and susceptibilities
06/17/2004CA2508544A1 Methods for improving secondary metabolite production in fungi
06/17/2004CA2508232A1 Protein binding to akt2
06/17/2004CA2507494A1 Rationally designed antibodies
06/17/2004CA2507443A1 Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof
06/16/2004EP1428880A1 Kidney-specific urate transporter and gene thereof
06/16/2004EP1428876A1 Novel amide hydrolase gene
06/16/2004EP1428870A1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation
06/16/2004EP1428826A2 Crystal forms of cytostatics
06/16/2004EP1427841A2 Nucleic acid-associated proteins
06/16/2004EP1427838A1 Plant enzymes for bioconversion
06/16/2004EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination
06/16/2004EP1427825A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
06/16/2004EP1427823A2 High throughput directed evolution by rational mutagenesis
06/16/2004EP1427822A2 Nucleic acid for cloning vector
06/16/2004EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
06/16/2004EP1427818A2 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains
06/16/2004EP1427811A1 Erythrocytic cells and method for preserving cells
06/16/2004EP1427809A1 Method for transforming i amycolatopsis sp. /i dsm 9991 and dsm 9992
06/16/2004EP1427808A1 Lactic acid producing bacteria for use as probiotic organisms in the human vagina
06/16/2004EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
06/16/2004EP1427758A2 Compositions and methods of treating diabetes
06/16/2004EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
06/16/2004EP1427750A1 Modified transferrin fusion proteins
06/16/2004EP1427746A2 Protein and nucleic acid expression systems
06/16/2004EP1427744A2 A system for antibody expression and assembly
06/16/2004EP1427742A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
06/16/2004EP1009844B1 IMPROVED $i(AGROBACTERIUM)-MEDIATED TRANSFORMATION OF PLANTS
06/16/2004EP1009810B1 Mutant thermomonospora spp. cellulase
06/16/2004EP1005540B1 Ikk-beta proteins, nucleic acids and methods
06/16/2004EP0791078B1 Methods for drug screening
06/16/2004EP0753058B1 High-alkaline protease and its use
06/16/2004EP0738318B1 Catabolite non-repressed substrate-limited yeast strains
06/16/2004EP0672133B1 TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES
06/16/2004CN1505915A Apparatus for using optical tweezers to manipulate materials
06/16/2004CN1505682A Methods and compositions for simultaneous saccharification and fermentation
06/16/2004CN1505681A A novel protein, a genes encoding therefor and a method of using the same
06/16/2004CN1505680A Biological compositions for solid waste treatment
06/16/2004CN1505679A Alkaline protease variants, and detergents and cleaning agents containing the same
06/16/2004CN1505678A Lactic acid bacteria as agents for treating and preventing allergy